2025 China Blood Testing Market Revenue Opportunities Report
Description
The 2025 China Blood Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the blood testing market in China are Roche Diagnostics, Sysmex Corporation, Abbott Laboratories, and Bio-Rad Laboratories. Roche dominates the IVD market globally and holds a significant market share in China, specializing in immunological and biochemical diagnostics. Sysmex China provides high-end hematology and blood coagulation analyzers that are widely used in large medical institutions, backed by advanced Japanese technology. Abbott Laboratories offers a broad range of diagnostic products in China, including clinical chemistry and molecular diagnostics. Bio-Rad focuses on blood typing and immunoassay systems, contributing to the expanding blood testing infrastructure in the country.
These companies leverage advanced technologies and extensive R&D to maintain competitive edges in China's burgeoning blood testing market, which is forecasted to grow rapidly with a CAGR of over 10% through 2030. They also benefit from strong local distribution networks and ongoing collaboration with Chinese hospitals and laboratories to enhance diagnostic accuracy and efficiency. Alongside these international giants, domestic firms like Hangzhou Biotest and Shanghai Kehua Bio-Engineering are also significant players, focusing on reagent and assay development to complement the market's needs. The combined efforts of these four key global players sustain much of the high-end blood testing capabilities available in China today.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the blood testing market in China are Roche Diagnostics, Sysmex Corporation, Abbott Laboratories, and Bio-Rad Laboratories. Roche dominates the IVD market globally and holds a significant market share in China, specializing in immunological and biochemical diagnostics. Sysmex China provides high-end hematology and blood coagulation analyzers that are widely used in large medical institutions, backed by advanced Japanese technology. Abbott Laboratories offers a broad range of diagnostic products in China, including clinical chemistry and molecular diagnostics. Bio-Rad focuses on blood typing and immunoassay systems, contributing to the expanding blood testing infrastructure in the country.
These companies leverage advanced technologies and extensive R&D to maintain competitive edges in China's burgeoning blood testing market, which is forecasted to grow rapidly with a CAGR of over 10% through 2030. They also benefit from strong local distribution networks and ongoing collaboration with Chinese hospitals and laboratories to enhance diagnostic accuracy and efficiency. Alongside these international giants, domestic firms like Hangzhou Biotest and Shanghai Kehua Bio-Engineering are also significant players, focusing on reagent and assay development to complement the market's needs. The combined efforts of these four key global players sustain much of the high-end blood testing capabilities available in China today.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
